Takeda Pharmaceutical is a little bit closer to grabbing some necessary cash by unloading its stake in the chemicals business Wako Pure Chemical Industries Ltd.
Shares of Bone Therapeutics dropped slightly after the company announced a change in leadership and ended plans to hold a clinical trial in the United States.
Hampton, N.J.-based Celldex Therapeutics announced recently that it planned to acquire Kolltan Pharmaceuticals. In addition to the news from its third-quarter 2016 financial report, the company indicated it had $203.2 million in cash, cash equivalents and marketable securities at the end of the third quarter. Is this a hint the company will do more acquisitions?
Essential medicines could be provided for as little as $1-$2 a month per person in developing countries, experts said as they called on governments to boost efforts to ensure everyone can access basic healthcare.
Despite advances that have made treatments safer and more effective, childhood cancer survivors do not appear to have experienced gains in long-term health outcomes, a new study suggests.
Scientists at Stanford University School of Medicine have used the CRISPR gene-editing tool to repair the gene that causes sickle cell disease in stem cells.
Three members of the U.S. Senate Judiciary Committee said Mylan NV appears to have greatly overcharged the military for its lifesaving allergy treatment EpiPen.
The World Health Organization revised guidelines on antenatal care, saying pregnant women should have twice as many contacts with health providers – eight – as it recommended previously.
As Merck KGaA winds up its business operations in Pakistan, employees are demanding appropriate severance pay for long-time service to the German-based company Dawn, Pakistan’s oldest English-language newspaper reported.